SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is facing increased volatility as investors weigh strong AI-driven demand and positive earnings guidance against concerns over sector-wide valuation and potential shifts in export-dependent revenue. The community remains divided between those viewing recent dips as strategic loading opportunities and those concerned that elevated expectations have created a crowded, overvalued trade.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is attracting significant community attention as investors speculate on potential government contracts and industry-wide tailwinds for domestic drone manufacturing. The stock is currently trending due to its role in the defense supply chain and community excitement surrounding upcoming earnings and potential federal funding catalysts.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors react to the accelerating lockup expiration of restricted shares, which community members are interpreting as both a potential catalyst for volatility and a sign of looming downward price pressure. Much of the discourse centers on debates over the fund's fair value relative to its underlying private holdings, with many participants actively discussing the looming Anthropic and Databricks IPOs as key drivers for the fund's long-term potential.

Workday, Inc. engages in the development of enterprise cloud applications for finance and human resources. The firm delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. It operates through the Cloud Applications segment. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday shares spiked following a report that private equity firm Silver Lake is in preliminary acquisition talks, fueling significant trading volume and a broader rally across the software sector. Community discussion remains polarized as traders debate whether the spike is a sustainable recovery for beaten-down SaaS names or an overextended reaction to unconfirmed buyout rumors.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending following the announcement of a strategic acquisition of Boeing's autonomous aviation subsidiaries, which has fueled intense debate over whether this move accelerates the company's defense revenue and autonomy capabilities or signals excessive dilution. Investors are actively split between those betting on long-term growth from these new partnerships and skeptics focused on ongoing cash burn and the volatility ahead of the company's upcoming earnings release.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is seeing intense community debate following its recent earnings, as investors weigh a significant year-over-year revenue decline against management's strategic pivot toward higher-margin AI systems integration. While some traders express frustration over customer concentration and poor stock performance, others are accumulating shares, citing healthy cash reserves and the potential for the company's Georgetown facility expansion to capture growing demand for AI infrastructure.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific Corp. is experiencing heightened social media discussion as investors debate whether recent insider purchases by the CEO and other executives signal a long-term bottom for the stock following a significant YTD decline. While some community members remain skeptical of the current downtrend, others see the heavy insider accumulation and ongoing institutional interest as a potential entry point for a rebound.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is seeing heightened interest following reports that its AI chip subsidiary, Kunlunxin, is targeting a major IPO in Hong Kong, which investors view as a potential catalyst for unlocking significant valuation. While the community remains divided, with some highlighting the company's AI cloud growth and autonomous driving capabilities, others are expressing frustration over stagnant price action and geopolitical risks.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing significant downward pressure following an analyst downgrade and uncertainty surrounding a CFO leadership transition, despite the company's robust customer growth and recent regulatory wins. Investors are actively debating whether this pullback represents an attractive long-term entry point for a dominant fintech or if broader macroeconomic headwinds and credit concerns will continue to weigh on the stock.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is trending as investors digest the recent leadership change with Donn Casale taking over as President, while the company maintains a strong balance sheet and continues its global expansion efforts despite ongoing market volatility. The stock remains a focal point for high short-interest activity and speculation regarding potential CVS formulary coverage and competitive dynamics in the epinephrine market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$OBX (NP) 
 
$IOVA competitor in TIL on radar after today&#39;s decline (at least for DD list to learn more)  
 
No IL2 administration= could be given outpatient 
 
Guiding for topline data from registration-enabling cohort in melanoma by year-end 2027  
 
(admittedly, VERY far behind Amtagvi + has to contend with $REPL Tudriqev and $IMTX anzu-cel)

CB, Structural Biologist

Obvs Not Telling

Danny Rizzi

$IOVA totally agree ATC network is the moat (scale is key, also indication expansion using existing base will be fun to watch)

StockTwits Web

Jonathan Faison

Obsidian Therapeutics Inc.

Iovance Biotherapeutics Inc

Replimune Group Inc

Immatics N.V

 competitor in TIL on radar after today's decline (at least for DD list to learn more)  
 
No IL2 administration= could be given outpatient 
 
Guiding for topline data from registration-enabling cohort in melanoma by year-end 2027  
 
(admittedly, VERY far behind Amtagvi + has to contend with 

@JFais don’t forget they have to build/scale/optimize a cell therapy centre too.